正在加载视频...

视频加载失败

It has been fun seeing how commercially available options around polygenic risk score selection have evolved over the past five years. Herasight has emerged as *the* player to watch. Loved having Jonathan Anomaly on the pod to discuss what Herasight is up to!

27,712 次观看 • 6 个月前 •via X (Twitter)

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频